Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome

Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome

Nonalcoholic fatty liver disease (NAFLD) is considered a manifestation of metabolic syndrome (MS) and is characterized by the accumulation of triglycerides and a varying degree of hepatic injury, inflammation, and repair. Moreover, peroxisome-proliferator-activated receptors (PPARs) play a critical...

Full description

Bibliographic Details
Main Authors: Agustina Cano-Martínez, Rocío Bautista-Pérez, Vicente Castrejón-Téllez, Elizabeth Carreón-Torres, Israel Pérez-Torres, Eulises Díaz-Díaz, Javier Flores-Estrada, Verónica Guarner-Lans, María Esther Rubio-Ruíz
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
inflammation
liver damage
toll-like receptor 4
P2Y2 receptor
metabolic syndrome
resveratrol
Online Access:https://www.mdpi.com/1422-0067/22/16/8939

Similar Items

Similar Items